HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lack of myristoylation of poliovirus capsid polypeptide VP0 prevents the formation of virions or results in the assembly of noninfectious virus particles.

Abstract
We previously described the generation of a set of mutations into a cDNA of poliovirus type 1 in the myristoylation signal of the capsid polypeptide VP4 (D. Marc, G. Drugeon, A.-L. Haenni, M. Girard, and S. van der Werf, EMBO J. 8:2661, 1989). Genomic transcripts synthesized in vitro from the mutated cDNAs were found to be noninfectious upon transfection of permissive cells, and this property correlated with the lack of VP0 myristoylation in vivo. In the study presented here, we analyzed the assembly intermediates that could be recovered from cells transfected with the mutated transcripts. We found that 14S pentamers could still assemble to a certain extent with an unmyristoylated VP0. Furthermore, viral particles sedimenting at 150S and containing capsid polypeptides VP1 to VP4 and virus-specific RNA were detected in the transfected cells. However, these mature virions were less abundant than those recovered after transfection with an infectious transcript, and they were devoid of infectivity. The results suggest that VP0 myristoylation plays a role in the late steps of poliovirus assembly and that the myristate moiety of VP4 may be required in the early steps of poliovirus infection.
AuthorsD Marc, G Masson, M Girard, S van der Werf
JournalJournal of virology (J Virol) Vol. 64 Issue 9 Pg. 4099-107 (Sep 1990) ISSN: 0022-538X [Print] United States
PMID2166807 (Publication Type: Journal Article)
Chemical References
  • Myristic Acids
  • RNA, Viral
  • Viral Proteins
  • Myristic Acid
Topics
  • Amino Acid Sequence
  • Capsid (biosynthesis, genetics)
  • Cloning, Molecular
  • Escherichia coli (genetics)
  • HeLa Cells
  • Humans
  • Molecular Sequence Data
  • Mutation
  • Myristic Acid
  • Myristic Acids (metabolism)
  • Plasmids
  • Poliovirus (genetics, pathogenicity, physiology)
  • RNA, Viral (analysis, genetics)
  • Transcription, Genetic
  • Transfection
  • Viral Proteins (biosynthesis, isolation & purification)
  • Virion (genetics, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: